Research Nester published a report titled “Compounded Bioidentical Hormone Therapy Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global compounded bioidentical hormone therapy market in terms of market segmentation by type, product type, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with a detailed discussion on current and future market trends that are associated with the growth of the market.
The global compounded bioidentical hormone therapy market is projected to grow at a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. The market is segmented by type into estrogen, progesterone, and testosterone, out of which, the estrogen market is estimated to acquire a greater share over the forecast period on account of a large number of women seeking out a medication for preventing the severe effects of menopause.
The global compounded bioidentical hormone therapy market is expected to thrive, owing to the increasing health awareness amongst the people. Furthermore, the diseases such as thyroid disorders, insulin resistance, osteoporosis, and fibromyalgia are prevailing at an unprecedented rate and compounded bioidentical hormone therapy is proving to be beneficial to prevent them. Owing to these reasons, the global compounded bioidentical hormone therapy is projected to propel over the forecast period.
Regionally, the global compounded bioidentical hormone therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to gain a notable share over the forecast period, owing to the increase in investment in the health sector. On the other hand, the market in the Europe region is also projected to flourish during the forecast period owing to the increasing health awareness amongst the people.
The research is global in nature and covers a detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Growing Prevalence of Thyroid amongst Women to boost the Market Growth
The American Thyroid Association states that 1 in 8 women develop thyroid disorder during her lifetime.
The compounded bioidentical hormone therapy is proving to be successful in preventing thyroid disorders, insulin resistance, osteoporosis, and fibromyalgia. Moreover, scientists all over the world are striving to find out a concrete solution to cure the hormonal disorders occurring in men and women. Bioidentical hormone therapy is capable of eliminating hormonal imbalances, which is the reason the global compounded bioidentical hormone therapy market is estimated to propel over the forecast period.
However, associated adverse health hazards are expected to operate as a key restraint to the growth of the global compounded bioidentical hormone therapy market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global compounded bioidentical hormone therapy which includes company profiling of Biote Medical, LLC, Neuva Aesthetics, Defy Medical, LLC, The biostation, Noven Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Novo Nordisk A/S, Therapeutics MD Inc, and Bayer AG. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global compounded bioidentical hormone therapy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Ask Industry Experts about this Report @ https://www.researchnester.com/sample-request-4088
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]